Abstract

In the course of the introduction of the Swiss flat rate per case system (SwissDRG) on 1 January 2012 to contain costs in the health care system, a paradigm shift was made in the billing of health care services, away from cost recovery to service financing. In order to cushion any negative effects in this regard due to the introduction, various measures were included by the legislator in the Federal Health Insurance Act (KVG) - one of these protective measures was acute and transitional care (Padrutt, 2019). Acute and transitional care (AÜP) was anchored in Art. 25a para. 2 KVG as part of the reorganisation of care financing. This 14-day prescription by a hospital doctor for a follow-up solution after a hospital stay was intended to prevent so-called ‚bloody discharges‘ - i.e. people should not be discharged home in need of treatment and care due to the shortened duration of treatment and stay (Padrutt, 2019; Zou et al., 2020). Nevertheless, EAP is very rarely prescribed in the inpatient setting in Switzerland or used by those affected.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call